scPharmaceuticals buy BiotechBee
Start price
29.09.22
/
50%
€6.15
Target price
31.12.24
€8.00
Performance (%)
-23.25%
End price
10.10.22
€4.72
Summary
This prediction ended on 10.10.22 with a price of €4.72. The price of scPharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.25%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| scPharmaceuticals | - | - | - | - |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% | 49.502% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% | 76.916% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% | 48.519% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% | 58.900% |
According to BiotechBee what are the pros and cons of scPharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year